跳转至内容
Merck
CN
  • SirT7 auto-ADP-ribosylation regulates glucose starvation response through mH2A1.

SirT7 auto-ADP-ribosylation regulates glucose starvation response through mH2A1.

Science advances (2020-08-25)
Nicolás G Simonet, Joshua K Thackray, Berta N Vazquez, Alessandro Ianni, Maria Espinosa-Alcantud, Julia Morales-Sanfrutos, Sarah Hurtado-Bagès, Eduard Sabidó, Marcus Buschbeck, Jay Tischfield, Carolina De La Torre, Manel Esteller, Thomas Braun, Mireia Olivella, Lourdes Serrano, Alejandro Vaquero
摘要

Sirtuins are key players of metabolic stress response. Originally described as deacetylases, some sirtuins also exhibit poorly understood mono-adenosine 5'-diphosphate (ADP)-ribosyltransferase (mADPRT) activity. We report that the deacetylase SirT7 is a dual sirtuin, as it also features auto-mADPRT activity. SirT7 mADPRT occurs at a previously undefined active site, and its abrogation alters SirT7 chromatin distribution. We identify an epigenetic pathway by which ADP-ribosyl-SirT7 is recognized by the ADP-ribose reader mH2A1.1 under glucose starvation, inducing SirT7 relocalization to intergenic regions. SirT7 promotes mH2A1 enrichment in a subset of nearby genes, many of them involved in second messenger signaling, resulting in their specific up- or down-regulation. The expression profile of these genes under calorie restriction is consistently abrogated in SirT7-deficient mice, resulting in impaired activation of autophagy. Our work provides a novel perspective on sirtuin duality and suggests a role for SirT7/mH2A1.1 axis in glucose homeostasis and aging.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
单克隆抗-FLAG® M2 小鼠抗, 1 mg/mL, clone M2, affinity isolated antibody, buffered aqueous solution (50% glycerol, 10 mM sodium phosphate, and 150 mM NaCl, pH 7.4)
Sigma-Aldrich
戴斯-马丁氧化剂, 97%
Sigma-Aldrich
抗-HA 兔抗, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
抗-LC3B 兔抗, ~1 mg/mL, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
抗-泛腺苷二磷酸核糖结合试剂, from Escherichia coli
Sigma-Aldrich
MISSION® esiRNA, targeting human H2AFY